Publications
2018
J Clin Microbiol. 2018 Dec 12. pii: JCM.01800-18. doi: 10.1128/JCM.01800-18
Evaluation of the Amplidiag CarbaR + MCR kit for the accurate detection of carbapenemase-producing and colistin-resistant bacteria
Girlich D, Bernabeu S, Grosperrin V, Langlois I, Begasse C, Arangia N, Creton E, Cotellon G, Sauvadet A, Dortet L, Naas T.
Learn more about Amplidiag® CarbaR+MCR.
Helicobacter. 2018 Dec 12:e12560. doi: 10.1111/hel.12560
Molecular diagnosis of Helicobacter pylori infection in gastric biopsies: Evaluation of the Amplidiag® H. pylori + ClariR assay
Hays C, Delerue T, Lamarque D, Burucoa C, Collobert G, Billöet A, Kalach N, Raymond J.
Learn more about Amplidiag® H. pylori+ClariR.
Anaerobe, Volume 52, August 2018, Pages 111-114
Evaluation of a novel molecular assay to diagnose toxigenic strains of Clostridium difficile
Catherine Eckert,Thomas Devallière, Rabab Syed-Zaidia, Valérie Lalande, Frédéric Barbut.
Learn more about Amplidiag® C. difficile+027.
Pediatr Infect Dis J. 2018 May;37(5):424-428
Potential Diarrheal Pathogens Common Also in Healthy Children in Angola
Pelkonen T,Dos Santos MD, Roine I, Dos Anjos E, Freitas C, Peltola H, Laakso S, Kirveskari J
Learn more about Amplidiag® Bacterial GE.
Learn more about Amplidiag® Stool Parasites.
Learn more about Amplidiag® Viral GE.
J Clin Microbiol. 2018 Feb 22;56(3). pii: e01092-17. doi: 10.1128/JCM.01092-17
Evaluation of the Amplidiag CarbaR+VRE Kit for Accurate Detection of Carbapenemase-Producing Bacteria
Oueslati S, Girlich D, Dortet L, Naas T.
Learn more about Amplidiag® CarbaR+VRE.
2016
Journal of Microbiological Methods 128 (2016) 61–65
Evaluation of a multiplex real-time PCR kit Amplidiag® Bacterial GE in the detection of bacterial pathogens from stool samples
Anniina Rintala, Eveliina Munukka, Andrej Weintraub, Måns Ullberg, Erkki Eerola.
Learn more about Amplidiag® Bacterial GE.
Clin Microbiol Infect 2016; 22: 535–541
Prospective study of pathogens in asymptomatic travellers and those with diarrhoea: aetiological agents revisited
T. Lääveri, J. Antikainen, S. H. Pakkanen, J. Kirveskari, A. Kantele.
Learn more about Amplidiag® Bacterial GE.
2015
Expert Review of Molecular Diagnostics , Volume 15, 2015 - Issue 9
Differentiating virulent 027 and non-027 Clostridium difficile strains by molecular methods
Silja Mentula, Sanna Laakso, Outi Lyytikäinen, Juha Kirveskari.
Learn more about Amplidiag® C. difficile+027
Posters
2019
ECCMID 2019, Amsterdam, Netherlands
Johanna Haiko, Tanja Holma, Jenni Antikainen, Anu Pätäri-Sampo; Molecular carbapenemase tests Eazyplex SuperBug Complete B, Novodiag CarbaR+, and Amplidiag CarbaR+MCR, provide high sensitivity in the detection of carbapenemase-positive bacteria
Learn more about Novodiag® CarbaR+ and Amplidiag® CarbaR+MCR
2018
RICAI 2018, Paris, France
L Cavalié, D Dubois, P Floch, M Grare, C Massip, C Roques Ceschin, C Souesme, F Auvray, H Guet Revillet, E Oswald; Détection des entéro-pathogènes par la trousse Amplidiag Bacterial GE (Mobidiag).
Learn more about Amplidiag® Bacterial GE.
Delphine Girlich, Sandrine Bernabeu, Victor Grosperrin, Isabelle Langlois, Chris;ne Begasse, Nicolas Arangia, Elodie Creton, Garance Cotellon, Aimie Sauvadet, Laurent Dortet, Thierry Naas; Evaluation of the Amplidiag Carba + MCR kit for the accurate detec&on of carbapenemase-producing and colistin resistant bacteria.
Learn more about Amplidiag® CarbaR+MCR.
P. Bogaerts, W. Bouchahrouf, T-D Huang et Y. Glupczynski; Evaluation of Amplidiag CarbaR+MCR on clinical isolates.
Learn more about Amplidiag® CarbaR+MCR.
International Symposium Salmonella and Salmonellosis (I3S) 2018, St. Malo, France
Charlotte Renaudat, Corinne Ruckly, Monique Lejay-Colin, Isabelle Carle, Simon Le Hello; Diversity of Salmonella, Shigella and Escherichia colistrains in response to a multiplex real-time PCR kit Amplidiag® Bacterial GE.
Learn more about Amplidiag® Bacterial GE.
XXIXe Congrès National de la Société Française d’Hygiène Hospitalière (SF2H) 2018, Montpellier, France
Ravry E., Cizeau F., Ducellier D.,Courbin V., Sainteorose V , Darty M., Decousser JW.; Portage d'entérobactéries présentant une résistance acquise à la colistine: quand on cherche, on trouve!
Learn more about Amplidiag® CarbaR+MCR.
JFHOD 2018, Paris, France
Trombert-Paolantoni S., Figarella P., Faivre S., Clabaut A., Hedbaut E.; Détection de Helicobacter pylori et de la résistance à la clarithromycine par PCR dans les selles et les biopsies gastriques : étude d’une trousse.
Learn more about Amplidiag® H. pylori+ClariR.
2017
ECCMID 2017 , Vienna, Austria
Oueslati S., Girlish D., Bonnin R., Dortet L., Naas T.; Evaluation of Amplidiag CarbaR kit for the accurate detection of carbapenemase-producing bacteria.
Learn more about Amplidiag® CarbaR+VRE.
Rasoanandrasana S., Jacquier H., Benmansour H., Bidet P., Cambau E., Raskin L., Bonacorsi S., Berçât B.; Use of Amplidiag Bacterial GE assay in the diagnosis of bacterial diarrhea.
Learn more about Amplidiag® Bacterial GE.
JNI 2017, Saint Malo, France
S. Oueslati, N. Fortineau, D. Girlich, L. Dortet, T. Naas; Evaluation of Amplidiag CarbaR-VRE kit for the detection of carbapenemase-producing bacteria.
Learn more about Amplidiag® CarbaR+VRE.
EHMSG Workshop 2017 (European Helicobacter and Microbiota Study Group), Bordeaux , France
Lucie Bénéjat-Bruhl, Astrid Ducournau, Emilie Bessède, Philippe Lehours, Francis Mégraud; Evaluation of two new molecular kits for detection of Helicobacter pylori and the mutations associated with clarithromycin resistance.
Learn more about Amplidiag® H. pylori+ClariR.
RICAI 2017, Paris, France
C. Burucoa, B. Pichard, T. Barrioz, F. Prevost, M. Wangermez, G. Fotsing, P-A. Haineaux, L. Serres, E. Vuillemin, P. Vasseur, F. Charier, E. Pithon, C. Plouzeau, J. Cremniter, A. Michaud, C. Silvain; Performances de la PCR Amplidiag Helicobacter pylori dans les selles.
Learn more about Amplidiag® H. pylori+ClariR.
C. Hays, C. Burucoa, D. Lamarque, N. Kalach, G. Collobert, A. Billoet, C. Plainvert, J. Raymond; Diagnostic de l’infection à Helicobacter pylori sur biopsie gastriques: évaluation du kit Amplidiag® H. pylori+ClariR.
Learn more about Amplidiag® H. pylori+ClariR.
Y. Glupczynski, M. Hoebeke, W. Bouchahrouf, T-D. Huang, C. berhin, P. Bogaerts; Evaluation of the Amplidiag® H. pylori+ClariR PCR kit.
Learn more about Amplidiag® H. pylori+ClariR.
Trombert-Paolantoni S., Figarella P., Faivre S., Clabaut A., Hedbaut E.; Détection de Helicobacter pylori et de la résistance à la clarithromycine par PCR dans les selles et les biopsies gastriques : étude d’une trousse.
Learn more about Amplidiag® H. pylori+ClariR.
Mikrobiologiskt vårmöte 2017, Karlskrona, Sweden
Raged El-Ali, Ilona Vereb, Ann Cathrine Petersson; Implementering av Amplidiag® H. pylori+ ClariR för Helicobacter-PCR från biopsier.
Learn more about Amplidiag® H. pylori+ClariR.
2016
RICAI 2016, Paris, France
Eckert C., Devallière T., Syed-Zaidi R., Couturier J., Lalande V., Barbut F.; Evaluation of a novel molecular assay to detect toxigenic strains of Clostridium difficile.
Learn more about Amplidiag® C. difficile+027.
Oueslati S., Girlich D., Dortet L., Naas T.; Evaluation of Amplidiag CarbaR kit for the detection of carbapenemase-producing bacteria.
Learn more about Amplidiag® CarbaR+VRE.
ID Week 2016, New Orleans, US
Tuula Pelkonen, Irmeli Roine, Elisabete Dos Anjos, César Freitas, Heikki Peltola, Sanna Laakso, Juha Kirveskari; Multiplex real-time PCR in the diagnosis of acute diarrhea in Children in Luanda, Angola.
Learn more about Amplidiag® Bacterial GE.
2015
ECCMID 2015, Copenhagen, Denmark
Kirveskari J., Rintala A.,Munukka E., Weintraub A., Laakso S., Kurkela J., Eerola E.; Evaluation of real-time PCR based assay for bacterial gastroenteritis pathogens.
Learn more about Amplidiag® Bacterial GE.
ICDS 2015, 5th International Clostridium difficile Symposium, Bled, Slovenia
Kirveskari J., Rintala A.,Munukka E., Weintraub A., Laakso S., Kurkela J., Eerola E.; Differentiating virulent 027 and non-027 Clostridium difficile strains by molecular methods.
Learn more about Amplidiag® C. difficile+027.
Presentations
2018
RICAI 2018, Paris, France
Nadji S.; Détection des gènes de carbapénémases dans les écouvillons rectaux avec la solution Amplidiag®
Learn more about Amplidiag® solution.
2017
ECCMID 2017 , Vienna, Austria
Razakandrainibe R., Fréalle E., Nourrisson C., Valot S., Dutoit E., Favennec L., Kapel N., Poirier P., Dalle F.; Multicentric Evaluation of a New Real-Time PCR Assay for Cryptosporidium spp.
Learn more about Amplidiag® Stool Parasites.
2016
ECCMID 2016, Amsterdam, The Netherlands
Jokiranta S., Enroth H., Kirveskari J., Bruhl-Benejat L.; Lunch seminar – Amplidiag, wider access to rapid, reliable and comprehensive information for gastrointestinal infection diagnostics.
Learn more about Amplidiag® solution.
RICAI 2016, Paris, France
Duployez C., Armand S., Galichet S., Dr Loiez C., Dr Wallet F.; Essai MOBIDIAG, Amplidiag BacterialGE, Août –Septembre 2016.
Learn more about Amplidiag® Bacterial GE.
Mobidiag featured in the News
2019
Bonnier Business Forum´s Hoiva&Terveys, January 2019 (web)
Mobidiag aims at developing innovative molecular diagnostics for antibiotic resistance – read our CEO’s latest interview on the topic of antibiotic resistance and the company’s future plans.
Talouselämä, January 2019 (web & print pp. 25)
The article features Mobidiag innovative solutions to fight against superbacteria and antibiotic resistances, as well as the latest 10 million euros investment from Chinese company Autobio Diagnostics.
2018
Spectra biologie n°236, September-October 2018, pp. 44-45
The article presents the results of the multicentric prospective study carried out in the framework of the Hepystool Hospital Clinical Research Project on 1,200 patients with the evaluation of the multiplex qPCR test Amplidiag® H. pylori+ClariR directly from stool samples.
Biomedical Scientist, November 2018, pp. 27
The article features the successful evaluation by the Leicester Royal Infirmary of Amplidiag® Easy, the automated solution for routine diagnostic screening by Mobidiag.
Kauppalehti Optio, October 2018, pp. 4-5
The article focuses on Novodiag® solution, the automated molecular diagnostic system allowing rapid and reliable results directly from patient sample.
Practical Patient Care, n°PPC021, April 2018, pp. 45
The article focuses on Novodiag® solution, the automated molecular diagnostic system allowing rapid and reliable results directly from patient sample.
La lettre de l'infectiologue, Tome XXXIII, n°1, January-February 2018, pp. 42
Coverage of the launch of Novodiag® solution in December 2017, Mobidiag's new on-demand system for rapid diagnostics of infectious diseases.
Chambre de Commerce Franco-Finlandaise (CCFF), January 2018 (web)
Interview of our CEO Tuomas Tenkanen and highlights on what makes Mobidiag such an innovative and dynamic company.
Pharmaceutiques, January 2018, pp. 38
Coverage of the new Novodiag® solution for rapid diagnostics of infectious diseases.
2017
Décideurs Magazine, December 2017 (web)
Coverage of the launch of Novodiag® solution in December 2017, Mobidiag's new on-demand system for rapid diagnostics of infectious diseases.
Blue Wings, Finnair Magazine, November-December 2017, pp. 75
In this article, our CEO Tuomas Tenkanen is presenting our upcoming Novodiag® molecular diagnostics solution. It also presents how Mobidiag is bringing alternative solutions to the routine diagnostics of infectious diseases by making rapid and cost-effective DNA-based technology accessible to all sizes of clinical laboratories.
TECAN Newsletter August 2017, pp. 26
The article “Perfect synergy for molecular diagnostics” covers the partnering between Mobidiag and TECAN for the development of the Amplidiag® Easy system, the automated platform for nucleic acid extraction and PCR plate set-up. Amplidiag Easy enables high volume screening and antibiotic resistance testing for gastrointestinal pathogens directly from stool samples.
Biologistes infos, Février-Mars 2017, pp. 18-20
Following the 36e Réunion interdisciplinaire de chimiothérapie anti-infectieuse (RICAI) in Paris at the end of 2016, the French magazine Biologiste infos has chosen to come back on 3 key presentations regarding Helicobacter pylori. H. pylori is responsible of most chronic gastritis and treatments have shown some limits due to resistances, overmedication, therapeutic failures, etc. New solutions such as PCR tests are addressed in this article, including Mobidiag’s test Amplidiag® H. pylori+ClariR.
Practical Patient Care (ECCMID 2017 edition), April 2017, pp. 33
Serving the European clinical diagnostics market, Mobidiag develops solutions to advance the diagnosis of infectious diseases. In this article, Sakari Jokiranta, MD, PhD, specialist in clinical microbiology and medical director of United Medix Laboratories – a client of the group explains what makes Mobidiag’s Amplidiag® H. pylori+ClariR and Amplidiag® Stool Parasites diagnostics solutions so unique.
2016
This one page article presents Mobidiag and explains how innovative molecular diagnostics can help avoid unnecessary use of antibiotics and enable a quicker and more accurate treatment decision.